1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. Asia Pacific Pharmaceutical Excipients Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. Asia Pacific Pharmaceutical Excipients Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. Asia Pacific Pharmaceutical Excipients Market Regional Analysis
6.2 Asia Pacific Pharmaceutical Excipients Market Revenue 2020-2028 (US$ Million)
6.3 Asia Pacific Pharmaceutical Excipients Market Forecast Analysis
7. Asia Pacific Pharmaceutical Excipients Market Analysis – by Product
7.1 Organic Chemicals
- 7.1.1 Overview
- 7.1.2 Organic Chemicals: Asia Pacific Pharmaceutical Excipients Market – Revenue and Forecast, 2020-2028 (US$ Million)
7.2 Inorganic Chemicals
- 7.2.1 Overview
- 7.2.2 Inorganic Chemicals: Asia Pacific Pharmaceutical Excipients Market – Revenue and Forecast, 2020-2028 (US$ Million)
7.3 Other Products
- 7.3.1 Overview
- 7.3.2 Other Products: Asia Pacific Pharmaceutical Excipients Market – Revenue and Forecast, 2020-2028 (US$ Million)
8. Asia Pacific Pharmaceutical Excipients Market Analysis – by Functionality
8.1 Fillers and Diluents
- 8.1.1 Overview
- 8.1.2 Fillers and Diluents: Asia Pacific Pharmaceutical Excipients Market – Revenue and Forecast, 2020-2028 (US$ Million)
8.2 Suspending and Viscosity Agents
- 8.2.1 Overview
- 8.2.2 Suspending and Viscosity Agents: Asia Pacific Pharmaceutical Excipients Market – Revenue and Forecast, 2020-2028 (US$ Million)
8.3 Coating Agents
- 8.3.1 Overview
- 8.3.2 Coating Agents: Asia Pacific Pharmaceutical Excipients Market – Revenue and Forecast, 2020-2028 (US$ Million)
8.4 Binders
- 8.4.1 Overview
- 8.4.2 Binders: Asia Pacific Pharmaceutical Excipients Market – Revenue and Forecast, 2020-2028 (US$ Million)
8.5 Preservatives
- 8.5.1 Overview
- 8.5.2 Preservatives: Asia Pacific Pharmaceutical Excipients Market – Revenue and Forecast, 2020-2028 (US$ Million)
8.6 Emulsifying Agents
- 8.6.1 Overview
- 8.6.2 Emulsifying Agents: Asia Pacific Pharmaceutical Excipients Market – Revenue and Forecast, 2020-2028 (US$ Million)
8.7 Other Functionalities
- 8.7.1 Overview
- 8.7.2 Other Functionalities: Asia Pacific Pharmaceutical Excipients Market – Revenue and Forecast, 2020-2028 (US$ Million)
9. Asia Pacific Pharmaceutical Excipients Market Analysis – by Type of Formulation
9.1 Oral Formulations
- 9.1.1 Overview
- 9.1.2 Oral Formulations: Asia Pacific Pharmaceutical Excipients Market – Revenue and Forecast, 2020-2028 (US$ Million)
9.2 Topical Formulations
- 9.2.1 Overview
- 9.2.2 Topical Formulations: Asia Pacific Pharmaceutical Excipients Market – Revenue and Forecast, 2020-2028 (US$ Million)
9.3 Parenteral Formulations
- 9.3.1 Overview
- 9.3.2 Parenteral Formulations: Asia Pacific Pharmaceutical Excipients Market – Revenue and Forecast, 2020-2028 (US$ Million)
9.4 Other Formulations
- 9.4.1 Overview
- 9.4.2 Other Formulations: Asia Pacific Pharmaceutical Excipients Market – Revenue and Forecast, 2020-2028 (US$ Million)
10. Asia Pacific Pharmaceutical Excipients Market – Asia-Pacific Analysis
10.1 Overview
10.2 Asia-Pacific
- 10.2.1 Asia Pacific Pharmaceutical Excipients Market Breakdown, by Key
Country, 2023 and 2028 (%)
- 10.2.1.1 Asia Pacific Pharmaceutical Excipients Market – Revenue and
Forecast Analysis – by Country
- 10.2.1.1 China:
Asia Pacific Pharmaceutical Excipients Market – Revenue and Forecast to 2028 (US$ Million)
- 10.2.1.1.1 China: Asia Pacific Pharmaceutical Excipients Market Breakdown, by Product
- 10.2.1.1.2 China: Asia Pacific Pharmaceutical Excipients Market Breakdown, by Functionality
- 10.2.1.1.3 China: Asia Pacific Pharmaceutical Excipients Market Breakdown, by Type of Formulation
- 10.2.1.2 India:
Asia Pacific Pharmaceutical Excipients Market – Revenue and Forecast to 2028 (US$ Million)
- 10.2.1.2.1 India: Asia Pacific Pharmaceutical Excipients Market Breakdown, by Product
- 10.2.1.2.2 India: Asia Pacific Pharmaceutical Excipients Market Breakdown, by Functionality
- 10.2.1.2.3 India: Asia Pacific Pharmaceutical Excipients Market Breakdown, by Type of Formulation
- 10.2.1.3 Japan:
Asia Pacific Pharmaceutical Excipients Market – Revenue and Forecast to 2028 (US$ Million)
- 10.2.1.3.1 Japan: Asia Pacific Pharmaceutical Excipients Market Breakdown, by Product
- 10.2.1.3.2 Japan: Asia Pacific Pharmaceutical Excipients Market Breakdown, by Functionality
- 10.2.1.3.3 Japan: Asia Pacific Pharmaceutical Excipients Market Breakdown, by Type of Formulation
- 10.2.1.4 Australia:
Asia Pacific Pharmaceutical Excipients Market – Revenue and Forecast to 2028 (US$ Million)
- 10.2.1.4.1 Australia: Asia Pacific Pharmaceutical Excipients Market Breakdown, by Product
- 10.2.1.4.2 Australia: Asia Pacific Pharmaceutical Excipients Market Breakdown, by Functionality
- 10.2.1.4.3 Australia: Asia Pacific Pharmaceutical Excipients Market Breakdown, by Type of Formulation
- 10.2.1.5 Rest of Asia-Pacific:
Asia Pacific Pharmaceutical Excipients Market – Revenue and Forecast to 2028 (US$ Million)
- 10.2.1.5.1 Rest of Asia-Pacific: Asia Pacific Pharmaceutical Excipients Market Breakdown, by Product
- 10.2.1.5.2 Rest of Asia-Pacific: Asia Pacific Pharmaceutical Excipients Market Breakdown, by Functionality
- 10.2.1.5.3 Rest of Asia-Pacific: Asia Pacific Pharmaceutical Excipients Market Breakdown, by Type of Formulation
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. Industry Landscape
12.1 Overview
12.2 Market Initiative
12.3 Partnerships and Collaborations
12.4 Other Developments
13. Company Profiles
13.1 Archer-Daniels-Midland Co
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 AshLand Inc
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Avantor Inc
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 BASF SE
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 Evonik Industries AG
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 JRS PHARMA GmbH & Co. KG
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 MEGGLE GmbH & Co KG
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 Roquette Freres SA
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 The Dow Chemical Co
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
13.10 The Lubrizol Corp
- 13.10.1 Key Facts
- 13.10.2 Business Description
- 13.10.3 Products and Services
- 13.10.4 Financial Overview
- 13.10.5 SWOT Analysis
- 13.10.6 Key Developments
14. Appendix
14.1 About Business Market Insights
14.2 List of Abbreviations